Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Purple Biotech Ltd. Sponsored ADR (PPBT) had Free Cash Flow of $-19.93M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-19.88M |
|
-- |
|
-- |
|
$22.27M |
|
$-22.27M |
|
$2.29M |
|
$-19.98M |
|
$-19.98M |
|
$-19.98M |
|
$-19.98M |
|
$-19.98M |
|
$-19.98M |
|
$-22.27M |
|
$-22.07M |
|
22.13M |
|
22.13M |
|
$-0.90 |
|
$-0.90 |
|
Balance Sheet Financials | |
$15.79M |
|
$0.15M |
|
$28.51M |
|
$44.30M |
|
$7.18M |
|
-- |
|
$2.82M |
|
$10.01M |
|
$34.30M |
|
$6.25M |
|
$34.30M |
|
25.24M |
|
Cash Flow Statement Financials | |
$-19.93M |
|
$13.88M |
|
$5.45M |
|
$15.03M |
|
$14.49M |
|
$-0.54M |
|
$1.88M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Free Cash Flow |
$-19.93M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-58.25% |
|
-319.48% |
|
-45.09% |
|
-58.25% |
|
$1.36 |
|
$-0.90 |
|
$-0.90 |